SnowBrand Evoxac
Executive Summary
Daiichi Pharmaceuticals' 100-rep sales force will promote cevimeline for the treatment of dry mouth symptoms in patients with Sjogren's syndrome. Evoxac, expected to launch in early April, will be manufactured by Yamanouchi Pharma Technologies, Inc. (1"The Pink Sheet" Jan. 17, p. 25)